In addition, a small molecule APOE4− targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model54, suggesting the potential APOE4 and Sirt1 pathways. The gene discussed is SIRT1; the disease is early-onset autosomal dominant Alzheimer disease.